Clinical Characteristics, Comorbidities, and Treatment in Patients with Pemphigus—A Single-Center Retrospective Study
2024

Clinical Characteristics and Treatment in Pemphigus Patients

Sample size: 69 publication Evidence: moderate

Author Information

Author(s): Natalia Welc, Sandra Ważniewicz, Paweł Głuszak, Maciej Spałek, Agnieszka Seraszek-Jaros, Magdalena Jałowska, Marian Dmochowski

Primary Institution: Department of Dermatology, Poznan University of Medical Sciences, Poland

Hypothesis

This study aimed to assess clinical characteristics, comorbidities, medication, and treatment of various types of pemphigus in patients.

Conclusion

Patients with pemphigus often have significant comorbidities and require a multidisciplinary approach for treatment.

Supporting Evidence

  • 79.31% of patients were diagnosed with pemphigus vulgaris (PV) and 26.09% with pemphigus foliaceus (PF).
  • The most common comorbidities were arterial hypertension, hypercholesterolemia, and diabetes mellitus.
  • 90% of PV patients and 94% of PF patients were treated with systemic glucocorticosteroids.
  • More than half of the patients received at least one glucocorticosteroid-sparing treatment.
  • A significant correlation was found between IgG deposits in DIF and anti-DSG1 antibodies in ELISA testing.
  • The mean age at diagnosis was 56.89 years, with PV patients diagnosed at 55.22 years and PF patients at 61.56 years.

Takeaway

Pemphigus is a rare skin disease that can be very serious, and patients often have other health problems that need to be treated together with their skin condition.

Methodology

Data were collected from 69 patients treated in the Department of Dermatology from 2016 to 2023, including demographic and clinical information.

Potential Biases

The study may not represent milder cases typically managed in outpatient settings.

Limitations

The study was conducted at a single center and lacked longitudinal follow-up for all patients.

Participant Demographics

The study group comprised 41 women and 28 men, with a mean age of 56.89 years.

Statistical Information

P-Value

p = 0.0217; p = 0.0031; p = 0.0298; p = 0.0054; p = 0.0339

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/antib13040103

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication